Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 459.5 g/mol |
---|---|
Molecular Formula | C20H25N7O6 |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 9 |
Exact Mass | 459.18663154 g/mol |
Monoisotopic Mass | 459.18663154 g/mol |
Topological Polar Surface Area | 199 A^2 |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 865 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
30
PharmaCompass offers a list of Levomefolate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levomefolate manufacturer or Levomefolate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levomefolate manufacturer or Levomefolate supplier.
PharmaCompass also assists you with knowing the Levomefolate API Price utilized in the formulation of products. Levomefolate API Price is not always fixed or binding as the Levomefolate Price is obtained through a variety of data sources. The Levomefolate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AN-9013 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AN-9013, including repackagers and relabelers. The FDA regulates AN-9013 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AN-9013 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AN-9013 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AN-9013 supplier is an individual or a company that provides AN-9013 active pharmaceutical ingredient (API) or AN-9013 finished formulations upon request. The AN-9013 suppliers may include AN-9013 API manufacturers, exporters, distributors and traders.
click here to find a list of AN-9013 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
AN-9013 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AN-9013 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AN-9013 GMP manufacturer or AN-9013 GMP API supplier for your needs.
A AN-9013 CoA (Certificate of Analysis) is a formal document that attests to AN-9013's compliance with AN-9013 specifications and serves as a tool for batch-level quality control.
AN-9013 CoA mostly includes findings from lab analyses of a specific batch. For each AN-9013 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AN-9013 may be tested according to a variety of international standards, such as European Pharmacopoeia (AN-9013 EP), AN-9013 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AN-9013 USP).